$VRSK

Verisk Analytics officer plans $603K stock sale

Verisk Analytics officer Lee Shavel plans to sell 3,535 shares worth $603K on October 1, 2026, via a broker-assisted cashless sale after exercising stock options. Earlier sales of 2,500 and 3,535 shares were made in July, August, and September 2026.

Original reporting
Published Oct 1, 2026, 8:06 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 2, 2026, 7:31 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$VRSK
Neutral
medium confidence
Mentioned
$VRSK
Relevance
4/10
AlphAI data visualization · based on stocktitan.net
Decision brief

The 30-second read

$VRSKNeutralLow
01

Why it matters

A $603K insider sale by an officer is a modest event; traders may watch for any follow‑on sales or larger insider activity.

02

Market read

The filing provides a fresh, small‑scale insider sell signal for Verisk Analytics (VRSK).

03

What to watch

Potential upcoming compensation grants or stock option exercises that may offset the dilution effect.

Relevance 4/10Novelty 4/10Timing: today

Background

Form 4 filings disclose insider transactions and are monitored for potential signals about company outlook.

Company-level read

Ticker impact

$VRSKNeutralMedium confidence
Context

Officer Lee Shavel filed a Form 4 on Oct 1, 2026 disclosing a cashless sale of 3,535 shares worth $603,424.50.

Expected impact

possible slight downward pressure as the market prices the insider sell.

Evidence & confidence

The transaction size is modest (<$1M) and involves a non‑executive officer, limiting material impact but still noteworthy for short‑term traders.

Market effects

Minimal; the sale does not affect the broader data‑analytics sector.

None; the filing is company‑specific.

Low; no broader market implications.

Counterpoint

The sale could be routine liquidity management and not indicative of negative sentiment.

Key entities

  • Lee Shavel

    Officer at Verisk Analytics who sold 3,535 shares.

Related articles

$VRSKHighAI 8/10

RBC Capital reiterates Verisk Analytics stock rating at Outperform

RBC Capital reiterated an Outperform rating and $230 price target for Verisk Analytics (VRSK) after a court ruling on its AccuLynx acquisition. The Delaware Supreme Court ordered Verisk to pursue FTC approval and close the $2.35B deal, awarding AccuLynx costs. Verisk will comply, with the transaction subject to FTC review. The deal may constrain share buybacks and increase leverage. Verisk's Q2 earnings and revenue slightly beat estimates, and BMO Capital raised its price target to $248.

$VRSKMed

VRSK Maintained by Barclays -- Price Target Lowered to $225

Barclays maintained an Overweight rating on Verisk Analytics (VRSK) but lowered its price target from $275 to $225. The company's stock is trading at $179.17, which GuruFocus estimates is 44.4% undervalued. Verisk has a GF Score of 78/100, indicating strong profitability and growth, but lower momentum. Insider activity shows significant selling, with $2.55 million in sales over the past three months.

$VRSKMed

Is Verisk’s Q2 Beat, Buyback and AI Push Altering The Investment Case For Verisk Analytics (VRSK)?

Verisk Analytics (VRSK) reported Q2 2026 earnings and revenue above estimates, reaffirmed its 2026 outlook, and announced a $200M share repurchase. The company emphasized growth in AI and data analytics for insurance clients. Verisk projects $3.8B in revenue and $1.3B in earnings by 2029, with a 24% upside to its current price. The company's high debt levels and interest expenses remain key risks.

$VRSKMedAI 8/10

Verisk (VRSK) Down 4.7% Since Last Earnings Report: Can It Rebound?

Verisk (VRSK) shares fell 4.7% since its last earnings report. Q2 2026 earnings beat estimates at $1.98 per share, up 5.3% YoY. Revenue rose 4.3% to $806.3M. Underwriting and claims revenues increased 3.5% and 6.3% respectively. EBITDA grew 4.2% but net income declined 9.8% due to higher taxes and interest. The company maintained 2026 guidance and approved a dividend. Estimates have trended downward, with a Zacks Rank #3 (Hold).